Open AccessTreatment of a chronic anal fissure with a botulin toxin A injection and fissurectomy
Author(s) -
Alejandro Andicoechea Agorría,
José Manuel Del Casar Lizcano,
Esther Barbón Remis,
Jimy Harol Jara Quezada,
José Carlos Fernández Fernández,
María Del Rosario Sánchez Sánchez,
Isabel Quintela Baizán,
Francisco Vivoso Piñero
Publication year - 2019
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2019.6202/2019
Subject(s) - medicine , surgery , urethral sphincter , hypertonia , anal fissure , botulinum toxin , anal sphincter , sphincter , botulism , retrospective cohort study , conservative treatment , anesthesia , urinary incontinence , biology , genetics
pharmacological treatment of a chronic anal fissure (CAF) achieves healing in half of cases and lateral internal sphincterotomy (LIS) is the definite treatment. The objective of this study was to assess the combination of fissurectomy and botulin toxin A (BTA) injection.